These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15096417)

  • 1. Donepezil use in Down syndrome.
    Kishnani PS; Sullivan JA; Spiridigliozzi GA; Heller JH; Crissman BG
    Arch Neurol; 2004 Apr; 61(4):605-6. PubMed ID: 15096417
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholinergic therapy for Down's syndrome.
    Kishnani PS; Sullivan JA; Walter BK; Spiridigliozzi GA; Doraiswamy PM; Krishnan KR
    Lancet; 1999 Mar; 353(9158):1064-5. PubMed ID: 10199357
    [No Abstract]   [Full Text] [Related]  

  • 3. Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study.
    Prasher VP; Adams C; Holder R;
    Int J Geriatr Psychiatry; 2003 Jun; 18(6):549-51. PubMed ID: 12789681
    [No Abstract]   [Full Text] [Related]  

  • 4. Donepezil use in the treatment of dementia associated with Down syndrome.
    Cipriani G; Bianchetti A; Trabucchi M
    Arch Neurol; 2003 Feb; 60(2):292; author reply 292. PubMed ID: 12580720
    [No Abstract]   [Full Text] [Related]  

  • 5. Down syndrome and Alzheimer disease: response to donepezil.
    Lott IT; Osann K; Doran E; Nelson L
    Arch Neurol; 2002 Jul; 59(7):1133-6. PubMed ID: 12117361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of donepezil on cognitive functioning in Down syndrome.
    Johnson N; Fahey C; Chicoine B; Chong G; Gitelman D
    Am J Ment Retard; 2003 Nov; 108(6):367-72. PubMed ID: 14561111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donepezil for Down's syndrome.
    Kishnani PS; Spiridigliozzi GA; Heller JH; Sullivan JA; Doraiswamy PM; Krishnan KR
    Am J Psychiatry; 2001 Jan; 158(1):143. PubMed ID: 11136652
    [No Abstract]   [Full Text] [Related]  

  • 8. The emergence of pharmacotherapies for cognitive function in Down syndrome.
    Capone GT
    Am J Med Genet A; 2010 Dec; 152A(12):3026-7. PubMed ID: 21108389
    [No Abstract]   [Full Text] [Related]  

  • 9. Open-label study of donepezil in chronic poststroke aphasia.
    Berthier ML; Hinojosa J; Martín Mdel C; Fernández I
    Neurology; 2003 Apr; 60(7):1218-9. PubMed ID: 12682346
    [No Abstract]   [Full Text] [Related]  

  • 10. Donepezil for dementia with Lewy bodies: a case study.
    Aarsland D; Brønnick K; Karlsen K
    Int J Geriatr Psychiatry; 1999 Jan; 14(1):69-72. PubMed ID: 10029938
    [No Abstract]   [Full Text] [Related]  

  • 11. Getting donepezil into the nursing home.
    Finucane TE
    J Am Geriatr Soc; 2003 Jan; 51(1):133-4; author reply 134. PubMed ID: 12534861
    [No Abstract]   [Full Text] [Related]  

  • 12. Does donepezil improve well-being for dementia due to Alzheimer's disease?
    Birks J
    Neuroepidemiology; 2005; 24(3):168-9. PubMed ID: 15677877
    [No Abstract]   [Full Text] [Related]  

  • 13. Donepezil for nursing home patients with dementia: a reinterpretation of the evidence.
    Steinman MA; Covinsky KE
    J Am Geriatr Soc; 2003 Jan; 51(1):132; author reply 132-3. PubMed ID: 12534859
    [No Abstract]   [Full Text] [Related]  

  • 14. An open-label trial of donepezil (aricept) in the treatment of persons with mild traumatic brain injury.
    Kaye NS; Townsend JB; Ivins R
    J Neuropsychiatry Clin Neurosci; 2003; 15(3):383-4; author reply 384-5. PubMed ID: 12928519
    [No Abstract]   [Full Text] [Related]  

  • 15. Donepezil in the treatment of vascular dementia.
    Ebell MH
    Am Fam Physician; 2004 Nov; 70(9):1681-2. PubMed ID: 15554484
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical-therapeutic study of dementia in people with Down syndrome and the effectiveness of donepezil in this population].
    Boada-Rovira M; Hernández-Ruiz I; Badenas-Homiar S; Buendía-Torras M; Tárraga-Mestre L
    Rev Neurol; 2005 Aug 1-15; 41(3):129-36. PubMed ID: 16047294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of vascular dementia treatment with cholinesterase inhibitors.
    Li Y; Meyer JS; Haque MA; Chowdhury MH; Hinh P; Quach M
    Int J Geriatr Psychiatry; 2002 Feb; 17(2):194-6. PubMed ID: 11813286
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse effects of donepezil in treating Alzheimer's disease associated with Down's syndrome.
    Hemingway-Eltomey JM; Lerner AJ
    Am J Psychiatry; 1999 Sep; 156(9):1470. PubMed ID: 10484967
    [No Abstract]   [Full Text] [Related]  

  • 19. Advertisements for donepezil. More convincing evidence of efficacy needs to be cited.
    Greenhalgh T
    BMJ; 1997 Dec; 315(7122):1623; author reply 1624. PubMed ID: 9437303
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cholinesterase inhibitors in the treatment of mixed dementia].
    Vasenina EE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7 Pt 2):98-103. PubMed ID: 23994939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.